The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,074,931 in first-year total cost, median $228,625.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IDM-X (50)]14
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- GENEVA FOUNDATION1
- GEORGIA INSTITUTE OF TECHNOLOGY1
- GUILD ASSOCIATES, INC.1
- HARVARD SCHOOL OF PUBLIC HEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Advancing mycobacteriophage aerosol for prevention of pulmonary infections1R21AI156807-01 | COLER, RHEA NLARSEN, SASHA E. | SEATTLE CHILDREN'S HOSPITAL, WA | $267,608 | ZRG1 |
| 2021 | TB Phage therapy: Optimizing delivery methods of mycobacteriophages to target intracellular Mycobacterium tuberculosis1R21AI156853-01 | JACOBS, WILLIAM ROBERT | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $251,938 | ZRG1 |
| 2021 | Using genetics and multi-scale imaging to understand the mechanisms underlying mycobacteriophage host choice1R21AI156772-01 | RUBIN, ERIC J. | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $250,961 | ZRG1 |
| 2021 | Engineering picoviruses with defined host range to combat drug-resistant staphylococci1R21AI156636-01 | DOKLAND, TERJEHATOUM, ASMA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $242,450 | ZRG1 |
| 2021 | Building re-usable phage and antibiotic treatments via exploitation of bacteria-phage co-evolutionary dynamics1R21AI156817-01 | BROWN, SAMUEL PAUL | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $236,700 | ZRG1 |
| 2021 | Understanding molecular rules governing bacteriophage specificity and virulence by high-throughput mutational and metagenomic scanning1R21AI156785-01 | RAMAN, SRIVATSAN | UNIVERSITY OF WISCONSIN-MADISON, WI | $232,813 | ZRG1 |
| 2021 | Novel Strategies for Treating Biofilm-Forming Pathogens with Phage Therapy1R21AI156798-01 | DENNEHY, JOHN JOSEPH | QUEENS COLLEGE, NY | $231,000 | ZRG1 |
| 2021 | Characterization of long-circulating phages isolated from in vivo mouse studies1R21AI156838-01 | WHITE, SIMON | UNIVERSITY OF CONNECTICUT STORRS, CT | $226,250 | ZRG1 |
| 2021 | Optimized methods for isolation and characterization of bacteriophage by VT-FACS1R21AI156831-01 | FLEMING, IAN | GUILD ASSOCIATES, INC., OH | $217,898 | ZRG1 |
| 2021 | Reducing Virulence Through the Suppression of Retractile Pili1R21AI156846-01 | ZENG, LANYINGZHANG, JUNJIE | TEXAS A&M AGRILIFE RESEARCH, TX | $216,769 | ZRG1 |
| 2021 | Towards the Translation of Synergistic Phage-Polymyxin Combination Therapy against Pandrug-resistant Klebsiella pneumoniae: A Systems Approach1R21AI156766-01 | LI, JIAN | MONASH UNIVERSITY | $210,731 | ZRG1 |
| 2021 | Phage resistance in Mycobacterium tuberculosis1R21AI156791-01 | HATFULL, GRAHAM F. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $207,225 | ZRG1 |
| 2021 | Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis1R21AI156828-01 | CAMILLI, ANDREWYEN, MINMIN | PHAGEPRO, INC., MA | $178,641 | ZRG1 |
| 2021 | A platform for genome mining of multidrug-resistant pathogens to develop therapeutic phages using synthetic biology1R21AI156850-01 | LE BRETON, YOANN STEPHANE | GENEVA FOUNDATION, WA | $103,947 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.